Presidential Lecture

2018/07/28

Presidential Lecture

Barriers of HCV Treatment in Asia Pacific

2018/07/28

Barriers of HCV Treatment in Asia Pacific

Barriers of HCV Treatment in China

2018/07/28

Barriers of HCV Treatment in China

New Therapies in HCV: Towards a Global Cure

2018/07/28

New Therapies in HCV: Towards a Global Cure

Clinical Outcomes of Anti Hepatitis C Therapy

2018/07/28

Clinical Outcomes of Anti Hepatitis C Therapy

Therapy of HCV: Remaining Challenges and Future Opportunities

2018/07/28

Therapy of HCV: Remaining Challenges and Future Opportunities

Hepatitis B in EU

2018/07/28

Hepatitis B in EU

Serum HBsAg and AFP Levels during Acute Hepatitis Flare of Chronic Hepatitis B: A New Look in the Natural Course and Antiviral Therapy

2018/07/28

Serum HBsAg and AFP Levels during Acute Hepatitis Flare of Chronic Hepatitis B: A New Look in the Natural Course and Antiviral Therapy

APASL HCV Guidelines: Liver Transplantation

2018/07/28

APASL HCV Guidelines: Liver Transplantation

Interferon-Free Treatment of Hepatitis C in Patients with

2018/07/28

Interferon-Free Treatment of Hepatitis C in Patients with

HCV Therapy-One Treatment for All Populations

2018/07/28

HCV Therapy-One Treatment for All Populations

2016/06/15

IC-HEP Expert Perspectives: Best of HCV – 2016 Spring Update

What's New

2026/01/16
Abstract Submission Deadline is Jan 20 !! APASL Oncology 2026 Tokyo !!

Abstract Submission Deadline has been extended to Jan 20, 2026 !! APASL Oncology 2026 Tokyo is waiting for your active … [Read more]
2026/01/13
APASL STC 2026 New Delhi will be held on Jan 30-31 !!

With the theme of Wilson India 2026~ Integrating Research into Clinical Practice in Wilson Disease ~, APASL STC 2026 New … [Read more]
2026/01/09
Call for Bidding !! APASL Annual Meeting in 2029 and STCs in 2027

Call for Bidding !! APASL Annual Meeting in 2029 and APASL STC/Oncology in 2027 At this time, we would like … [Read more]
2026/01/08
Please check out the latest article on Hepatology International !!

Read the findings from the ANCHOR randomized controlled trial, evaluating the efficacy and safety of combination therapy with entecavir, peginterferon … [Read more]
2026/01/06
Call for Abstracts of APASL-ONCOLOGY 2026 TOKYO!

APASL-ONCOLOGY 2026 TOKYO Abstract submission deadline has been extended until January 20, 2026 !　 https://www.apasl.info/wp-apasl/wp-content/uploads/2026/01/f1d9ce63a105a76047a73f8c42cbbb96.mp4 Dear Colleagues, A Happy New … [Read more]

What's New